Pediatric Cancer (Canada) PSP Terms of Reference
Introduction to the James Lind Alliance and priority setting
The James Lind Alliance (JLA) is a non-profit making initiative which was established in 2004 with the aim of enabling groups of patients, carers and clinicians to work together to agree priorities for health research. The JLA facilitates PSPs in particular health areas.
Each PSP consists of patients, carers and their representatives, and clinicians, and is led by a Steering Group. Collaboration between patients, carers and clinicians to set the research agenda is extremely rare, but vital in drawing issues to the attention of research funders that might not otherwise be suggested or prioritised.
The role of the PSP is to identify questions that have not been answered by research to date, and then to prioritise these. The first stage is to ask patients, carers and clinicians, often via an online survey, for unanswered questions about Pediatric Cancer Research Priorities. These questions are then assessed to check they are in scope for the PSP, and are checked and verified as true uncertainties. An interim prioritisation exercise then takes place, before a priority-setting workshop is convened where participants debate and finally arrive at a Top 10 list of research priorities.
The eventual aim is to turn these priorities into research questions, and for members of the Steering Group to work with researchers and research funders to obtain funding for that research.
All JLA will display all priorities on the JLA website. Further details about the JLA and PSPs are at http://www.jla.nihr.ac.uk/.
The Pediatric Cancer Priority Setting Partnership
Membership of the Steering Group
The Steering Group membership must be a balance of patients, carers and professionals.
It is agreed that for the Pediatric Cancer PSP, two of patient/carer representatives and two of healthcare professionals will need to be present in order for Steering Group meetings to go ahead and for decisions to be made.
Role of Steering Group members
Steering Group members are asked to contribute, as a minimum, their expertise and their time, and to be prepared to approach their established contacts and networks.
All Steering Group members are asked to commit to working according to the JLA principles:
- Inclusivity: working with other members respectfully and constructively and ensuring the full range of patient, carer and clinical stakeholder are involved in the PSP process
- Equality: patients, carers and clinicians, and the knowledge and experience they bring, are of equal value to the PSP
- Fairness and transparency: declaring any personals interests, and ensuring decisions and activities are documented openly
- Evidence based: ensuring the work of the PSP recognises the existing knowledge based for pediatric cancer treatment and survivorship and contributes to this through the PSP’s evidence checking and open publication of information from the PSP.
Members of the Steering Group will need to agree the resources (including time and expertise) that they will contribute to ensure that each stage of the process is completed. Members of the Steering Group will:
- Publicise the initiative to potential partners. This includes advising on membership of the PSP (to ensure a wide and representative group of patients, carers and clinicians) and emailing contacts to invite them to participate
- Publicise and participate in an initial awareness meeting if this takes place
- Take part in bi-monthly Steering Group meetings/teleconferences. It is usual for a Steering Group to meet either by teleconference or face to face on an approximately monthly basis in order to keep momentum around the PSP and to maintain their relationship as a team
- If unable to attend, submit comments ahead of the meeting. Where a Steering Group member is unable to attend a meeting, decisions made at the meeting will be respected
- Respond promptly with feedback on project materials by responding to emails
- Have oversight of the collection of evidence uncertainties from patients, carers, clinicians and existing literature
- Oversee and lend expertise to the data management process, including agreeing the scope and process for data-checking
- Have oversight of the interim priority setting stage
- Agree the final shortlist of questions to be taken to the final priority setting workshop
- Oversee the planning for the final priority-setting workshop, and help to publicise it. This is the one-day workshop that brings patients, carers and clinicians together to debate, rank and agree a final Top 10. It is only attended by patients, carers and the healthcare professionals or support workers who actively work with them. Typically not all members of the Steering Group attend, allowing space for new participants
- Ensure that the PSP’s working spreadsheet of uncertainties and the final prioritised list of questions are supplied to the JLA, for publication on the JLA website
- Help publicise the final top 10 uncertainties to the research community
- Be involved in the development of research questions from the agreed priorities, and work with research funders where necessary to provide any extra information they need.
Chair: The PSP will be chaired by Tamara Rader, a JLA Adviser. The JLA Adviser also Chairs and runs the final priority-setting workshop. The JLA Adviser’s role is to support and guide the PSP, as a neutral facilitator, ensuring that the process is followed in a fair, transparent way, with equal input from patients, carers and clinicians and their representatives.
Lead: Dr. Lindsay Jibb is the lead for the PSP. The Lead works closely with the JLA Adviser and the PSP coordinator to champion the PSP and ensure it is successfully promoted, completed and disseminated to funders.
Coordinator: Elham Hashemi is responsible for the coordination and administration of the PSP. This includes arranging all meetings and workshops, and ensuring that:
- Requests for agenda items are discussed with the group
- Papers are available at least a week before meetings
- Meeting notes are reviewed by the Chair, circulated within two weeks, and reviewed and agreed at the next meeting.
Information Specialist: Lily Ren is the Information Specialist for the PSP. Their role is to advise the Steering Group on data management and analysis strategies and agree these with the group. They also review and analyse the data collected, review existing evidence, and help develop the long list of questions, under the guidance and assurance of the Steering Group. It is helpful if the Information Specialist has content knowledge in the subject area of the PSP. However, if the Information Specialist is well supported by the Steering Group this may not be essential. The outputs delivered by the Information Specialist will be approved by the Steering Group.
Steering Group members are asked to declare any interests relevant to the Pediatric Cancer PSP. The JLA provides an example form, and the interests of each member will be shared among the group. This is to encourage a culture of openness and transparency. Relevant interests may be professional, personal or related to an interest in or involvement in clinical research. The same form asks Steering Group members to consider their agreement to being named in publicity about the PSP.
Researchers may sit on the Steering Group if the group feels this is appropriate and useful – the JLA Adviser will ensure that they do not have an undue influence on the outcome. Researchers who are currently clinically active may participate in the priority setting if they declare their interests.
The Pediatric Cancer PSP first Steering Group meeting will be on Monday, April 27th 2020. The steering group will decide on the timeline of the project.
Steering Group members
|Name||Affiliation||Role in Steering Group|
|Tamara Rader||James Lind Alliance||PSP Chair|
|Lindsay Jibb||The Hospital for Sick Children||PSP Lead|
|Elham Hashemi||The Hospital for Sick Children||PSP Coordinator|
|Lily Ren||The Hospital for Sick Children||Information Specialist|
|Dr. James Whitlock||The Hospital for Sick Children, The C17 Council||Steering Group member|
|Dr. Michael Taccone||The Hospital for Sick Children||Steering Group member|
|Dr. Daniel Morgenstern||SickKids Staff Oncologist||Steering Group member|
|Rachel Hamilton||The Hospital for Sick Children||Steering Group member|
|Perri Tutelman||Centre for Pediatric Pain Research at the IWK Health Centre||Steering Group member|
|Kathy Brodeur-Robb||C17 Executive member||Steering Group member|
|Adrienne Roode||Helena’s Hope||Steering Group member|
|Caroline Wai||Helena’s Hope||Steering Group member|
|Antonia Palmer||AC2ORN||Steering Group member|
|Sarah Calderwood||Helena’s Hope||Steering Group member|
|Helena Kirk||Helena’s Hope||Steering Group member|
|Geoffrey Fang||The Hospital for Sick Children||Steering Group member|